Background: Sleeve gastrectomy  is a surgical technique  to treat morbid obesity  by both restrictive  and  probably  hormonal  action.  Originally  developed  as a first  stage to  gastric bypass, it is more and more performed as a sole procedure. Therefore it is important to report results on weight loss and reduction in co-morbidity. Patients and methods:  Sixty morbidly obese patients (15 male, 45 female) were studied with a mean age 35 ±10.9, mean BMI of 47.4 ± 7.8 kglm? All were evaluated and managed by sleeve gastrectomy from January 2009 to January 2012 in the General Surgery Department, Zagazig University Hospitals, 30 patients were associated with co-morbidity. Preoperative demographic data, operative data and postoperative follow up at 3ms, 6ms, 12ms were collected. Results:  Laparoscopic  sleeve gastrectomy (LSG) was done in 59 patients with conversion to open  in one  patient;  major  postoperative  complication  was  bleeding  (1pt.).  The  mean operative time ofthe procedure including  anesthesia  was 155 ±18.5  min. The mean hospital stay was 3.1±.6days. The mean reduction in weight was 50 kg, reduction inBMJwas BMI of 17 ±4.9kgl m2 and reduction in %EWL was 48. 7± 15. Complete resolution was 76. 7% in 23 cases of co-morbidity patients. Conclusion: Sleevegastrectomy  can be performed safely with acceptable complication rates and good weight loss with good efficacy on the co-morbidity management